Home
Scholarly Works
Impact of the 21-gene Recurrence Score assay on...
Conference

Impact of the 21-gene Recurrence Score assay on the adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes in an academic centre in Ontario.

Authors

Torres S; Trudeau ME; Gandhi S; Warner E; Verma S; Pritchard KI; Petrella TM; Hew-Shue M; Chao C; Eisen A

Volume

34

Pagination

pp. e12026-e12026

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2016

DOI

10.1200/jco.2016.34.15_suppl.e12026

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team